The Patent Finder

Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof

Create Medicines, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2021/058104, filed Nov 4, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,628,218Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
In force
 · Medium confidence
Create Medicines, Inc.In force
Medium confidence
US 11,944,680Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
In force
 · Low confidence
Create Medicines, Inc.In force
Low confidence
Application 18/434,220Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
Pending
Not granted
Create Medicines, Inc.PendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Create Medicines, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited